Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Taiwan · Delayed Price · Currency is TWD

55.70

-1.10 (-1.94%)

Aug 20, 2026, 1:30 PM CST

-17.28% (1Y)

Market Cap	2.02B -18.9%
Revenue (ttm)	864.73M +20.0%
Net Income	149.13M +3.2%
EPS	4.06 +1.9%
Shares Out	36.33M
PE Ratio	13.71
Forward PE	n/a
Dividend	2.50 (4.46%)
Ex-Dividend Date	Jul 3, 2026

Volume	24,488
Open	55.80
Previous Close	56.80
Day's Range	55.10 - 55.80
52-Week Range	53.30 - 79.42
Beta	-0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Hantech Bio-Technology

Hantech Bio-Technology Co., Ltd., through its subsidiaries, engages in the manufacture, trade in, and distributes biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products in Taiwan and internationally. The company offers OEM & ODM manufacturer of liquid, jelly, and gel-type health supplements. It also provides aluminum foil bag designs; and aluminum foil-packaged beverage production activities. In addition, the company is involved in the manufacture of machinery and equipment; and trade in of health food raw ma... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2007

Employees 152

Stock Exchange Taipei Exchange

Ticker Symbol 1294

Full Company Profile

Financial Performance

In 2025, Hantech Bio-Technology's revenue was 778.54 million, an increase of 4.02% compared to the previous year's 748.42 million. Earnings were 139.05 million, a decrease of -10.68%.

Financial Statements